... to 18 based on the severity of COVID-19 pneumonia. Further, we categorized patients into two independent groups based on their renal function using the RIFLE and KDIGO criteria to define the acute kidney injury (AKI) and chronic kidney disease (CKD) groups. The first group (“AKI&CKD...

...Kai Zhu; Xinxin Li; Likun Gao; Mengyao Ji; Xu Huang; Yu Zhao; Wenxiu Diao; Yanqin Fan; Xinghua Chen; Pengcheng Luo; Lei Shen; Lili Li Introduction: Chronic kidney disease (CKD) is a major public health issue worldwide, which is characterized by irreversible loss of nephron and renal function...

...Ebba Sivertsson; Sara Ceder; Masaomi Nangaku; Peter Hansell; Lina Nordquist; Fredrik Palm Introduction: Chronic kidney disease (CKD) is a global health problem with increasing incidence which is closely associated with cardiac dysfunction. In CKD, uremic toxins accumulate as kidney function...

... Immunoglobulin A nephropathy Glomerulonephritis Corticosteroid Chronic kidney disease Immunoglobulin A nephropathy (IgAN) was first described in the late 1960s and is well recognized for its heterogeneity in clinical presentation, histopathology, disease trajectory, and treatment response [ 1...

...Yizeng Xu; Jing Yang; Fang Lu; Chaoyang Ye; Chen Wang Introduction: Chronic hypoxia is prevalent in chronic kidney disease (CKD), and blood oxygenation level-dependent magnetic resonance imaging (BOLD-MRI) provides noninvasive evaluation of renal oxygenation. This study aimed to explore...

...Ning Li; Zhao Wang; Xue Yang; Haitao Xie; Qinglong Gu; Jun Guo; Zhiqiang Li Introduction: Most chronic kidney disease (CKD) patients experience cardiovascular issues before commencing renal replacement therapy. An accuracy prediction model is helpful for physicians to assess cardiovascular...

...Xenophon Kassianides; Sunil Bhandari Modern intravenous iron compounds (e.g., ferric carboxymaltose [FCM] and ferric derisomaltose [FDI]) are utilized in the treatment of iron deficiency anemia in non-dialysis-dependent chronic kidney disease (ND-CKD). Product-specific alterations in the metabolism...

...Aleksandra Golenia; Norbert Zolek; Piotr Olejnik; Ewa Wojtaszek; Tomasz Glogowski; Jolanta Malyszko Background: Cognitive impairment (CI) in patients with chronic kidney disease, including those treated with renal replacement therapy, is a growing problem worldwide. Objectives: The study aimed...

...Rasmus Kirkeskov Carlsen; Dinah Sherzad Khatir; Danny Jensen; Henrik Birn; Niels Henrik Buus Introduction: Chronic kidney disease (CKD) is associated with cardiovascular disease (CVD) and death. Albuminuria is an established risk factor, but additional biomarkers predicting CKD progression or CVD...

...Emma Di Poi; GianLuca Colussi; Martina Bertoni; Ivan Giovannini; Barbara Tolusso; Gian Franco Ferraccioli; Elisa Gremese; Salvatore De Vita; Giulio Romano Introduction: If properly evaluated, chronic kidney disease can be found in up to 50% of patients with systemic sclerosis (SSc). The renal...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 SGLT2 inhibitor Chronic kidney disease Diabetic kidney disease Non-diabetic kidney disease Chronic...

...Ting Zhou; Shiyuan Wang; Yajing Pan; Xingtong Dong; Leiyun Wu; Jiali Meng; Jialing Zhang; Qi Pang; Aihua Zhang Introduction: Protein-energy waste (PEW) is a common complication in patients with chronic kidney disease (CKD), among which skeletal muscle atrophy is one of the most important clinical...

...; Frida M. De La Vega-Méndez; Juan A. Gómez-Fregoso; Francisco G. Rodríguez-García; Guillermo Navarro-Blackaller; Ramón Medina-González; Luz Alcantar-Vallin; Guillermo García-García Introduction: In patients with chronic kidney disease stages 4 and 5 (CKD stages 4–5) without dialysis and arterial...

... to compile data on chronic kidney disease. Total prevalence of CKD in Michigan 27% (as of 2019); 1% with ESRD. *Data not specified in census. In this exploratory study, on the broader context of race within medicine and the history eGFR calculations; we investigated how the use of Black race...

... investigated the association between fasting TG concentrations and chronic kidney disease (CKD). This study aimed to examine the association between casual (fasting or non-fasting) serum TG concentrations and new-onset CKD in the general Japanese population. Methods: We conducted a population-based...

... Organization pooled individual participant data from a community-based cohort study in Iwate prefecture. Chronic kidney disease (CKD) was estimated using the estimated glomerular filtration rate of cystatin C (eGFRcys). Individuals with a history of hyperuricemia or severe renal dysfunction (eGFRcys <15 mL...

...Marija Domislovic; Viktor Domislovic; Mirjana Fucek; Ana Jelakovic; Lana Gellineo; Zivka Dika; Bojan Jelakovic Introduction: The pandemic of obesity is strongly related to increase of chronic kidney disease (CKD) prevalence. The currently recommended CKD epidemiology collaboration (CKD EPI...

..., less is known about its association with albuminuria, the other key component of chronic kidney disease, in the community-dwelling adult population. We examined the association of the spot urinary sodium-to-potassium ratio with albuminuria and compared spot urinary and dietary sodium-to-potassium...

..., it is not known to what extent this phenomenon impacts kidney function in patients who are referred to a nephrology clinic for consultation for chronic kidney disease (CKD). Methods: We conducted a prospective observational study of patients referred to our nephrology clinic for a new evaluation of a rise in sCr...

... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Chronic kidney disease Blood...